Balaji Amines Limited · NSE:BALAMINES

Balaji Amines — Q1 FY2026 Earnings Presentation

40 slides from Balaji Amines's earnings presentation, Aug 5, 2025

  1. Slide 1: Exchange filing cover letter for Q1FY26 investor presentation

    5th August, 2025 To, The General Manager-Department of The Manager-Listing Department, Corporate Services, National Stock Exchange of India Limited, BSE Limited, "Exchange Plaza", 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block, Bandra-Kurla Complex, Dalal Street, Mumbai - 400 001. Bandra

  2. Slide 2: Investor Presentation – August 2025

    Investor Presentation – August 2025

  3. Slide 3: Disclaimer

    Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securiti

  4. Slide 4: Results Highlights, About Us, Historical Financial Performance, Annexures

    Results Highlights About Us Historical Financial Performance Annexures 3

  5. Slide 5: Q1FY26: Financial Highlights

    Q1FY26 : Financial Highlights (Rs. Crore) Standalone Revenue EBITDA PAT EBITDA & PAT Margin -3% 0% -2% 19% 20% 20% 338 327 327 64 64 64 41 40 40 12% 12% 12% Q1FY25 Q4FY25 Q1FY26 Q1FY25 Q4FY25 Q1FY26 Q1FY25 Q4FY25 Q1FY26 Q1FY25 Q4FY25 Q1FY26 Consolidated Revenue EBITDA PAT EBITDA & PAT Margin -7% -14

  6. Slide 6: Q1 FY26 - Consolidated Performance Highlights

    Q1 FY26 - Consolidated Performance Highlights Revenue from Operations for Q1FY26 stood at ₹ 367 crore, as compared to ₹ 361 crore in Q4FY25. Total volumes stood at 27,570 MT for Q1FY26 as against 25,871 MT in Q4FY25 keeping the performance track intact though the volume growth is seen. The stable co

  7. Slide 7: New Project Highlights (1/2)

    New Project Highlights (1/2) Update on New Projects Commissioned and New Proposed Products/Projects: • Dimethyl Ether (DME) : The project for manufacture of DME is under execution at Unit-IV. The Plant is expected to be commissioned during the FY 2025-26. This has an application in the Aerosol indus

  8. Slide 8: New Projects Highlights (2/2)

    New Projects Highlights (2/2) New expansion of Rs. 750 crs in Subsidiary Balaji Speciality Chemicals Limited • Investment is being made for wide range of products, including Hydrogen Cyanide (HCN), Sodium Cyanide (NaCN) 30%(Solution), Sodium Cyanide (NaCN) 100%(Solid), Ethylene Diamine Tetra Acetic

  9. Slide 9: Expansion Plans

    Expansion Plans EXECUTED ON SCHEDULE (Methylamines) IN PROGRESS (Dimethyl Ether) • Market Leader in Methylamines production in India with installed capacity of • Dimethyl Ether (DME) with a Capacity of 1,00,000 tons per annum under Phase-3 48,000 TPA being increased to 88,000 TPA expansion a new age

  10. Slide 10: Standalone Statement of Profit & Loss

    Standalone Statement of Profit & Loss Particulars (in Rs. Crore) Q1FY26 Q4FY25 Q-o-Q FY25 FY24 Y-o-Y Total Revenue 327 327 0% 1296 1359 -5% Raw Material 181 179 706 756 Employee expense 19 21 73 72 Other expenses 63 64 268 263 EBITDA 64 64 0% 249 267 -7% EBITDA Margin 20% 20% 19% 20% Depreciation 11

  11. Slide 11: Consolidated Statement of Profit & Loss

    Consolidated Statement of Profit & Loss Particulars (in Rs. Crore) Q1FY26 Q4FY25 Q-o-Q FY25 FY24 Y-o-Y Total Revenue 367 361 2% 1430 1671 -14% Raw Material 212 198 781 903 Employee expense 20 23 80 82 Other expenses 71 72 304 332 EBITDA 64 68 -6% 265 353 -25% EBITDA Margin 17% 19% 19% 21% Depreciati

  12. Slide 12: Results Highlights, About Us, Historical Financial Performance, Annexures

    Results Highlights About Us Historical Financial Performance Annexures 11

  13. Slide 13: Amines Industry – Unique but Critical Industry with growth potential

    Amines Industry – Unique but Critical Industry with growth potential Globally, ~61% of aliphatic amines and Top six companies control around 50% of In terms of the usage, Aliphatic Amines The Amines Market is projected to grow amine-based chemicals get consumed in the global capacities. China is the

  14. Slide 14: Balaji Amines – Pioneers in Amines & Specialty Chemicals

    Balaji Amines – Pioneers in Amines & Specialty Chemicals Forward integrated suite of products 50+ 40+ State-of-the-art manufacturing facilities fully equipped with Downstream products added based on strength of amine manufacturing which have value addition latest DCS technology Countries Product bas

  15. Slide 15: Diverse Portfolio Spanning Amines, Derivatives & Specialty Chemicals

    Diverse Portfolio Spanning Amines, Derivatives & Specialty Chemicals Particulars Amines Amine Derivatives Specialty & Other Chemicals o Aliphatic Amines find increasing consumption o Amine Derivatives are used to make further salts and applications in a Chemically mature Industry and other complex c

  16. Slide 16: Robust Manufacturing Backbone with Scalable Capacities

    Robust Manufacturing Backbone with Scalable Capacities Existing Installed Capacity Proposed Capacity Total Capacity after Product Application Areas (TPA) (TPA) Expansions (TPA) Methyl Amine 88,000 - 88,000 Pharma, Agro, Dye & Rubber Ethyl Amine 22,500 - 22,500 Pharma, Agro, Dye & Rubber DMAHCL / DMA

  17. Slide 17: Well-Positioned Across Essential and Evolving Industries

    Well-Positioned Across Essential and Evolving Industries Industry Wise - Revenue Breakup 3% 4% 3… 4% 3% 2% 4% 51% 26% Pharma Agrochem Paints & Resins Animal Feeds Oil & Gas Rubber Cleaning Chemicals Water Treatment Chemicals Dye and Textiles Others Investor Presentation 16

  18. Slide 18: Expanding Global Footprint Across Key Export Markets

    Expanding Global Footprint Across Key Export Markets • UK • Japan • US • Turkey • Argentina • Finland • Canada • Indonesia • Israel • Switzerland • India • Sri Lanka • Pakistan • Russia • Bangladesh • Malaysia • Oman • Singapore • Germany • Bahrein • Italy • Jordan • Egypt • Guatemala • South Africa

  19. Slide 19: Trusted by Industry Leaders Across the Globe

    Trusted by Industry Leaders Across the Globe Amines Amine Derivatives Specialty & Other Chemicals Investor Presentation 18

  20. Slide 20: Integrated Value Chain Enhancing Operational Resilience

    Integrated Value Chain Enhancing Operational Resilience Value-Added Products Specialization in logistics Preference for Local Sourcing Exposure to pharma sector Capex towards high-value Aliphatic Amines have huge Safety is a critical factor and Extensive usage in solvents led to derivatives and spec

  21. Slide 21: Distinctive Strengths Powering Our Competitive Edge

    Distinctive Strengths Powering Our Competitive Edge Extensive Geographical Presence Market Leadership and Unique Positioning Strategic manufacturing footprint and global supply chain ensure Largest manufacturer of Aliphatic Amines unmatched market responsiveness, cost-efficient logistics, and in Ind

  22. Slide 22: Focused Strategy to Enhance Value Across the Value Chain

    Focused Strategy to Enhance Value Across the Value Chain Target fast growing industries Value Added Products Cater to fast growing industries, namely, Focus towards high-value derivatives and pharmaceuticals, agro-chemicals, refineries, specialty chemicals with an aim to move up water treatment, rub

  23. Slide 23: Poised for the Next Phase of Scalable, Profitable Growth (1/2)

    Poised for the Next Phase of Scalable, Profitable Growth (1/2) Project Accorded Mega Strategically Located Plant Product Profile Balaji Specialty Chemicals Project Status Environmental clearance received In Phase-1 of Greenfield Project Electronic Grade DMC Existing Maharashtra’s Energy and Labour f

  24. Slide 24: Poised for the Next Phase of Scalable, Profitable Growth (2/2)

    Poised for the Next Phase of Scalable, Profitable Growth (2/2) New Products = First High Demand for Products Solar Power Plant Mover advantage Significant opportunity exists to The demand of Methylamines has The 20 MW Greenfield Solar Power introduce new products & gain First increased in India. Hig

  25. Slide 25: About Balaji Speciality Chemicals

    About Balaji Speciality Chemicals 01 02 03 Balaji Speciality Chemicals Limited (BSCL) is Commenced its commercial operations in June 2019 from Manufacturing products such as Ethylene Diamine (EDA), BAL owns 55% in subsidiary Balaji Speciality Chemicals Pvt. Ltd which is strategically located at Sola

  26. Slide 26: About Balaji Sarovar Premiere Hotel

    About Balaji Sarovar Premiere Hotel o Commenced Operations in October 2013 Hotel Balaji Sarovar Premier is the only 5 star hotel in Solapur o Invested Rs. 110 crore in the Hotel Project via mix of Debt and Equity o Tied up with Sarovar Group for the Management of the Hotel on Management Fee + Revenu

  27. Slide 27: Balaji Sarovar Premiere – Q1FY26 Operating Matrix

    Balaji Sarovar Premiere – Q1FY26 Operating Matrix Constitutes Rs 1,027 Lakhs 5,121 129 Rooms 3.14% of from Hotel Division Rs. ADR Total Revenue Business 75% Rs. 3,845 Occupancy Rate RevPAR Renowned Five Star Hotel In the City of Solapur ADR: Average Daily Rate RevPAR: Revenue per Available Room Inve

  28. Slide 28: Results Highlights, About Us, Historical Financial Performance, Annexures

    Results Highlights About Us Historical Financial Performance Annexures 27

  29. Slide 29: Consolidated Performance Highlights

    Consolidated Performance Highlights Revenue (Rs. Crs.) EBITDA (Rs. Crs.) PAT (Rs. Crs.) 2,338 2,371 637 624 418 406 1,671 1,318 1,430 379 353 244 232 265 159 2021 2022 2023 2024 2025 2021 2022 2023 2024 2025 2021 2022 2023 2024 2025 EBITDA Margin (%) PAT Margin (%) RoE (%) 28.8% 27.3% 18.5% 17.9% 31

  30. Slide 30: Strong Core ROCE Profile

    Strong Core ROCE Profile Particulars (Rs. Crs.) FY25 FY24 Consolidated Debt 11 20 During the year the following plants have been commissioned 1) Methylamines Plant Consolidated Networth 2018 1893 2) N-Butylamine Plant – Unit IV 3) Rooftop Solar Power Plants at various units Total Capital Employed 20

  31. Slide 31: Consistent Dividend Payout

    Consistent Dividend Payout 550% 550% 500% 300% 200% 160% FY20 FY21 FY22 FY23 FY24 FY25 Particulars (Rs. per share) FY20 FY21 FY22 FY23 FY24 FY25 Consolidated Book Value 206 281 406 524 584 623 Consolidated EPS 32 74 114 100 63 49 Dividend 3.20 4.00 6.00 10.00 11.00 11.00 Investor Presentation 30

  32. Slide 32: Results Highlights, About Us, Historical Financial Performance, Annexures

    Results Highlights About Us Historical Financial Performance Annexures 31

  33. Slide 33: Balaji Amines Ltd - Progressing steadily

    Balaji Amines Ltd - Progressing steadily 1 2 3 4 5 Unit 4: Increased Unit 4 : capacity utilization & Improvements at Greenfield projects of Greenfield Capex Phase - 2 & 3 capacity additions of Subsidiary Plant Subsidiary Plant Phase - 1 capex Capex for Phase 2 & 3 of Expansion and Investments to be

  34. Slide 34: Highly Experienced Management Team

    Highly Experienced Management Team Mr. A. Prathap Reddy Mr. N. Rajeshwar Reddy Executive Chairman Whole Time Director • Civil Engineer by Education. Incorporated BAL in 1988 • Commerce Graduate having over 48 years of • BAL's continuing success is a testimony to his experience across industries entr

  35. Slide 35: Awards & Certificates – A Testimony of our capabilities

    Awards & Certificates – A Testimony of our capabilities ISO Certificate Three Star Export House ISO Certificate BEST CEO (CHEMICAL INDUSTRY) AWARD TO SHRI ANDE PRATHAP REDDY BY BUSINESS TODAY GROUP ISO 9001 : 2015 Certificate Certificate of Merit - CHEMEXCIL First Award - CHEMEXCIL WHO GMP Certifica

  36. Slide 36: Awards & Certificates – A Testimony of our capabilities

    Awards & Certificates – A Testimony of our capabilities Mahatma Award for Sustainable “Company of the Year” in International Tourism & Product Innovator of the Year in Distinguished Contribution in the Excellent CSR in Water and Responsible Business Chemicals at FICCI Chemicals Hospitality Award For

  37. Slide 37: Awards & Recognition - A Testimony of our capabilities

    Awards & Recognition - A Testimony of our capabilities On January 28, 2025, Balaji Amines Limited was honored with the “Rasayan Udyog Shri” award by the Indian Chemical Society at its centennial celebration in Mumbai. Chairman Shri A. Pratap Reddy received the award from Prof. G. D. Yadav in the pre

  38. Slide 38: ESG & CSR Initiatives

    ESG & CSR Initiatives Donated Bus for Punyashlok Ahilyadevi Holkar Solapur University, Contructed classroom at RR Patil School & Jr College @ Constructed classroom at Baburao Patil Vidhyalay Gotewadi, Mohol, Solapur dt. 10.12.2024 Penur,Mohol, Solapur dt 07.06.2024 Solapur dt.09.10.2024 Constructed

  39. Slide 39: ESG & CSR Initiatives

    ESG & CSR Initiatives Constructed Classroom at ZPHS Chengal School, Mandal Bhimgal, Construction of Toilet Block at Indira Kale Prashala, Jalkotwadi, dt. Distributed Sanitary Napkin Incinerator and Vending Machine at Nizamabad, dt. 04.01.2025 25.03.2025 Vishwabhushan Vidyalay, Solapur dt.30.09.2024

  40. Slide 40: Thank You

    Company : Balaji Amines Ltd. CIN - L24132MH1988PLC049387 Email - cs@balajiamines.com cs@balajiamines.com www.balajiamines.com www.balajiamines.com Investor Relations Advisors : MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services Mr. Bhavya

Balaji Amines — Q1 FY2026 Earnings Presentation on 6ix